The European IPO market was subdued in 2023, but several European companies are expected to conduct rights offerings in 2024, following a slowdown in cash call activity in 2023. In Germany, only three companies went public in 2023 – Ionos, Thyssenkrupp Nucera and Schott Pharma. The total issue volume fell significantly to €1.9 billion, the second-lowest figure in the last ten years. Several companies are preparing for IPOs. Knut Sauer (Allen & Overy), Johannes Meier (Triton Partners), Marko Maschek (Marondo Capital) and Catherine Ford (Mergermarket) discuss the current outlook for IPOs in Germany as an exit channel for private equity.
Mergermarket Private Equity and M&A Forum Germany, April 23, 2024 Frankfurt.